The presented package image matches the product design registered with the Ukrainian regulatory authorities.
If you have noticed any differences, please call us at +380 44 490 75 22
Dosage form
Powder for injection 0.5 g intravenous or intramuscular adm., 1.0 g intravenous adm.
Active ingredient
1 vial contains amikacin sulfate (1:1.8) equivalent to 0.5 g or 1.0 g amikacin.
Indications
Infections caused by susceptible strains of amikacin microorganisms resistant to other aminoglycosides.

If you have information about any adverse effects or other drug-related problems, please fill in the form